BiomX Inc. (PHGE)
NYSEAMERICAN: PHGE · Real-Time Price · USD
0.5230
+0.0030 (0.58%)
At close: Sep 26, 2025, 4:00 PM EDT
0.5151
-0.0079 (-1.51%)
After-hours: Sep 26, 2025, 8:00 PM EDT
BiomX Market Cap
BiomX has a market cap or net worth of $13.89 million as of September 26, 2025. Its market cap has decreased by -21.61% in one year.
Market Cap
13.89M
Enterprise Value
9.22M
1-Year Change
-21.61%
Ranking
Category
Stock Price
$0.52
Market Cap Chart
Since July 17, 2019, BiomX's market cap has decreased from $101.67M to $13.89M, a decrease of -86.34%. That is a compound annual growth rate of -27.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2025 | 13.89M | 4.65% |
| Dec 31, 2024 | 13.27M | 3.09% |
| Dec 29, 2023 | 12.87M | 130.01% |
| Dec 30, 2022 | 5.60M | -87.59% |
| Dec 31, 2021 | 45.11M | -69.57% |
| Dec 31, 2020 | 148.28M | -32.95% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 17, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 665.99B |
| Johnson & Johnson | 425.53B |
| AbbVie | 388.63B |
| UnitedHealth Group | 318.63B |
| Novo Nordisk | 259.65B |
| Novartis AG | 238.19B |
| AstraZeneca | 233.83B |
| Abbott Laboratories | 233.03B |